pritumumab April 12, 2017 pritumumab Trade Name Orphan Indication Pancreatic cancer USA Market Approval USA USA Designation Date 2016-04-06 00:00:00 Sponsor Nascent Biotech, Inc.;8400 Miramar Road, Suite 247;San Diego, California, 92126
